A Study of NeuroVax™, a Novel Therapeutic TCR Peptide Vaccine for Pediatric Multiple Sclerosis

NCT02200718 · clinicaltrials.gov ↗

PHASE1

Phase

UNKNOWN

Status

12

Enrollment

INDUSTRY

Sponsor class

Conditions

Multiple Sclerosis

Interventions

BIOLOGICAL: NeuroVax
BIOLOGICAL: IFA Incomplete Freund's Adjuvant

Sponsor

Immune Response BioPharma, Inc.